TNFSF15 inhibits progression of diabetic retinopathy by blocking pyroptosis via interacting with GSDME

Hongkun Zhao,Yating Dai,Yunqin Li,Juanjuan Li,Hua Li

DOI: https://doi.org/10.1038/s41419-024-06499-8

2024-02-08

Cell Death and Disease

Abstract:Diabetic retinopathy is a common microvascular complication of diabetes and a leading cause of blindness. Pyroptosis has emerged as a mechanism of cell death involved in diabetic retinopathy pathology. This study explored the role of GSDME-mediated pyroptosis and its regulation by TNFSF15 in diabetic retinopathy. We found GSDME was upregulated in the progression of diabetic retinopathy. High glucose promoted GSDME-induced pyroptosis in retinal endothelial cells and retinal pigment epithelial cells, attributed to the activation of caspase-3 which cleaves GSDME to generate the pyroptosis-executing N-terminal fragment. TNFSF15 was identified as a binding partner and inhibitor of GSDME-mediated pyroptosis. TNFSF15 expression was increased by high glucose but suppressed by the caspase-3 activator Raptinal. Moreover, TNFSF15 protein inhibited high glucose- and Raptinal-induced pyroptosis by interacting with GSDME in retinal cells. Collectively, our results demonstrate TNFSF15 inhibits diabetic retinopathy progression by blocking GSDME-dependent pyroptosis of retinal cells, suggesting the TNFSF15-GSDME interaction as a promising therapeutic target for diabetic retinopathy.

cell biology

What problem does this paper attempt to address?

This paper attempts to solve the problem of pathological progression caused by GSDME - mediated pyroptosis in Diabetic Retinopathy (DR). Specifically, the study explored GSDME - mediated pyroptosis and its impact on retinal cells under hyperglycemic conditions, and further investigated how TNFSF15 inhibits this pyroptosis by interacting with GSDME, thereby slowing down the progression of diabetic retinopathy.

### Main research contents
1. **Expression of GSDME in diabetic retinopathy**:
- The study found that during the progression of diabetic retinopathy, the expression of GSDME was significantly up - regulated.
- Under hyperglycemic conditions, GSDME induces pyroptosis in retinal endothelial cells and retinal pigment epithelial cells, manifested as a large number of balloon - like vesicular structures on the cell membrane.

2. **Hyperglycemia activates caspase - 3 to cleave GSDME**:
- The hyperglycemic environment promotes the expression and activation of caspase - 3, and caspase - 3 cleaves GSDME to generate an N - terminal fragment with pyroptosis - execution function.
- Using the caspase - 3 activator Raptinal further enhanced this effect, resulting in more severe pyroptosis.

3. **Interaction between TNFSF15 and GSDME**:
- Through high - throughput transcriptome sequencing and protein - interaction screening, the study found that TNFSF15 can interact with GSDME.
- The expression of TNFSF15 increases under hyperglycemic conditions, but is inhibited by the caspase - 3 activator Raptinal.
- Molecular docking studies indicate that there is a highly probable binding between TNFSF15 and GSDME, forming multiple hydrogen - bond and salt - bridge interactions.

### Conclusion
This study reveals that TNFSF15 inhibits GSDME - mediated pyroptosis by interacting with GSDME, thereby protecting retinal cells from damage caused by hyperglycemia. This finding provides a theoretical basis for the development of new therapies targeting the TNFSF15 - GSDME axis, and is expected to bring new hope for the treatment of diabetic retinopathy.

### Formula presentation
- **caspase - 3 cleaves GSDME**:
\[
\text{caspase - 3} \rightarrow \text{cleaved - caspase - 3} \rightarrow \text{GSDME - NT}
\]
- **Molecular docking score**:
\[
\text{Confidence\_score} = \frac{1.0}{1.0 + e^{0.02\times(\text{Docking\_Score} + 150)}}
\]

Through these research results, the paper provides a new perspective for understanding the pathological mechanism of diabetic retinopathy and points out the direction for future treatment strategies.